Dr. Mark Stanchfield, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 226 9th Ave Se, Cut Bank, MT 59427 Phone: 406-873-5623 Fax: 406-873-5624 |
News Archive
AssureRx Health, Inc. today announced the closing of a $12.5 million Series C financing. The personalized medicine company, which provides clinically-relevant information to help physicians select the right drug for individual neuropsychiatric patients, will use the funds to increase commercial activities for its two flagship pharmacogenomic products, GeneSightRx Psychotropic and GeneSightRx® ADHD, as well as next generation product development activities.
Patients who have their wisdom teeth pulled and do not take antibiotics before surgery are twice as likely to get an infection after the surgery than those who take a single dose of antibiotics shortly before surgery, says Eastman Dental Center researchersYan-Fang Ren, DDS, PhD, MPH and Hans Malmstrom, DDS.
OSI Pharmaceuticals and Genentech have announced that the U.S. Food and Drug Administration (FDA) has approved, after priority review, Tarceva (erlotinib) for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) after failure of at least one prior chemotherapy regimen.
Male collegiate athletes have high rates of risk factors for infection with the cancer-causing human papillomavirus (HPV), but have low HPV vaccination rates and low awareness of their personal health risks, according to a study in the November issue of The Nurse Practitioner, published by Wolters Kluwer.
BSD Medical Corporation, a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that the Company has sold a MicroThermX Microwave Ablation System to the University of Miami Hospital and Clinics to include the Sylvester Comprehensive Cancer Center and the University of Miami Hospital.
› Verified 9 days ago